Taro Pharmaceutical Industries Ltd (NYSE:TARO)

100.54
Delayed Data
As of May 17
 -0.80 / -0.79%
Today’s Change
76.93
Today|||52-Week Range
109.42
+18.79%
Year-to-Date

Today’s Trading

Previous close101.34
Today’s open101.35
Day’s range99.72 - 102.11
Volume94,905
Average volume (3 months)67,251
Market cap$3.9B
Data as of 4:02pm ET, 05/17/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+51.23%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-24.73%
P/E ratio12.8
Price/Sales5.99
Price/Book1.79

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc-0.45-1.78%
UTHRUnited Therapeutics ...+2.01+2.27%
CBPOChina Biologic Produ...-0.71-0.76%
ACADACADIA Pharmaceutica...-0.63-2.46%
Data as of 4:00pm ET, 05/17/2019

Financials

Next reporting dateMay 20, 2019
EPS forecast (this quarter)$2.26
Annual revenue (last year)$661.9M
Annual profit (last year)$211.2M
Net profit margin31.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Uday Vijaykumar Baldota
Vice President &
Head-Operations
Itamar Karsenti
Corporate headquarters
Haifa Bay, Haifa

Forecasts